|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0005516,
umls-concept:C0007226,
umls-concept:C0030705,
umls-concept:C0035435,
umls-concept:C0174234,
umls-concept:C0205217,
umls-concept:C0205314,
umls-concept:C0229671,
umls-concept:C0333348,
umls-concept:C0441889,
umls-concept:C0679622,
umls-concept:C1419131
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2010-4-14
|
|
pubmed:abstractText |
Pentraxin 3 (PTX3), a key component of innate immunity, is a strong marker of disease severity in coronary artery disease (CAD). The aim of this study was to compare levels of serum PTX3 in CAD patients with and without inflammatory rheumatic disease (IRD) and in healthy controls.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
2151-4658
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
62
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
378-85
|
|
pubmed:meshHeading |
pubmed-meshheading:20391484-Aged,
pubmed-meshheading:20391484-Biological Markers,
pubmed-meshheading:20391484-C-Reactive Protein,
pubmed-meshheading:20391484-Case-Control Studies,
pubmed-meshheading:20391484-Coronary Artery Disease,
pubmed-meshheading:20391484-Female,
pubmed-meshheading:20391484-Humans,
pubmed-meshheading:20391484-Male,
pubmed-meshheading:20391484-Middle Aged,
pubmed-meshheading:20391484-Rheumatic Diseases,
pubmed-meshheading:20391484-Serum Amyloid P-Component
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Increased levels of serum pentraxin 3, a novel cardiovascular biomarker, in patients with inflammatory rheumatic disease.
|
|
pubmed:affiliation |
Feiring Heart Clinic, Feiring, and Hospital for Rheumatic Diseases, Lillehammer, Norway. i-hollan@online.no
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
